HENRY WROBLEWSKI: Open Payments
NPI 1730181785 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 33 payments from 7 companies in 2025. Trend: 2023 $459 · 2024 $688 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 24 | $350 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| Virtus Pharmaceuticals LLC | 2 | $31 |
| Fidia Pharma USA Inc. | 1 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| SCILEX PHARMACEUTICALS INC. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: XTAMPZA, RELISTOR, LEVORPHANOL TARTRATE, HYMOVIS, HORIZANT, ZTLido, QULIPTA.
Industry payments across NJ — which companies pay providers there.
